laush Posted June 1, 2002 Report Share Posted June 1, 2002 Prøv at læse denne artikel:http://www.thinkmuscle.com/articles/mcdona...omocriptine.htm Quote Link to comment Share on other sites More sharing options...
Jespernr Posted June 4, 2002 Report Share Posted June 4, 2002 Fed artikel, men jeg savner løsningen på at hæve ens setpoint.Men sådan som jeg forstår det så er der en bog som svarer på det spørgsmål.Hvilke bog er det?vhJespernr Quote Link to comment Share on other sites More sharing options...
b_skaal Posted June 4, 2002 Report Share Posted June 4, 2002 Jeg har lige skevet til forfatteren og spurgt om det - skal nok vende tilbage, hvis han gør det.God artikel i øvrigt, men har det på samme måde som Jesper: " Og svaret er....? "Hm, fik mailen tilbage i hovedet - jeg prøver senere...mvh mette Quote Link to comment Share on other sites More sharing options...
laush Posted June 4, 2002 Author Report Share Posted June 4, 2002 Bogen kan købes her: (det er en e-book)http://www.qfac.com/qfacmain.htmlI øvrigt tror jeg at at svaret på at holde ens set-point nede dvs. at holde fedtprocenten lav kan hjælpes på vej ved at spise sundt og sørge for at få de rigtige vitaminer, mineraler, fedtsyrer m.m., men det kræver også meget tid i en travl hverdag.I øvrigt er her et "abstract" fra en undersøgelse om bromocriptineMvh Lau Saugman HansenBromocriptine (Ergoset) reduces body weight and improves glucose tolerancein obese subjects.Cincotta AH, Meier AH.Ergo Science, Charlestown, Massachusetts 02129, USA.OBJECTIVE: A double-blind placebo controlled study investigated long-termeffects of Ergoset, a new quick release formulation of bromocriptine, onbody weight, body fat, and glucose tolerance in a group (n = 17) of obesesubjects who were instructed to follow a moderate hypocaloric diet. RESEARCHDESIGN AND METHODS: Obese individuals (> 25% body fat for men and > 30% bodyfat for women) were instructed to follow a calorie-restricted diet (70% ofweight maintaining based on study entry weight) and were randomized to dailytreatment with Ergoset (1.6-2.4 mg/day) or placebo at 0800 over an 18-weektreatment period. Oral glucose tolerance tests were performed on subjectsbefore initiation and again at termination of treatment. Body weight andbody fat (determined by skinfold measurements) were quantified every 2 weeksduring the course of treatment. RESULTS: Ergoset treatment for 18 weekssignificantly reduced body weight and body fat versus placebo (6.3 +/- 1.5and 5.4 +/- 1.1 kg vs. 0.9 +/- 1.0 and 1.5 +/- 0.6 kg. respectively, P <0.01). Ergoset, but not placebo, also improved glucose tolerance (P < 0.02);the stimulated area under the oral glucose tolerance curve was reduced by46% (from 121 +/- 23 to 64 +/- 32 mg.h-1.dl-1), while the stimulated areaunder the insulin curve was reduced by 30%. CONCLUSIONS: When combined withinstruction to follow a moderate hypocaloric diet, Ergoset, but not placebo,improves glucose tolerance and promotes significant weight and body fat lossin obese subjects over an 18- week treatment period. Quote Link to comment Share on other sites More sharing options...
b_skaal Posted June 5, 2002 Report Share Posted June 5, 2002 nå, ja der var jeg lidt for langsom - fik ellers en mail fra Lyle McD.Mette,Actually, the 'article' was the first chapter of the bromocriptine bookletin question, excerpted in whole. I guess Bryan didn't describe it as suchin the newsletter. Basically, it was simply the lead in to the rest of thebooklet (where explanations of how the body knows what's going on duringdieting, to how bromocriptine is one specific fix). The booklet can bepurchased in its entirety from http://www.qfac.comSincerely,Lyle McDonaldRart, når folk kan svare hurtigt ude i den store verden...mvh mette Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.